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Lipid profile in low birth weight  
newborns
Yuri V. Chernenkov, Larisa G. Bochkova, Irina I. Kadymova, Anton R. Kiselev*
The aim of the study was to assess lipid metabolism in premature infants to identify common patterns depending on birth weight. 
The levels of cholesterol, triglycerides, high- and low-density lipoproteins were determined in 173 infants with moderately low birth 
weight, very low birth weight and extremely low birth weight, including infants with intrauterine growth restriction, each weight 
category recorded during the neonatal period. The study showed that extremely low birth weight newborns with intrauterine growth 
restriction and very low birth weight newborns had significantly lower levels of lipid profile than infants with moderately low birth 
weight. It is necessary to expand the study of methods for correcting lipid spectrum in low birth weight infants for rehabilitation of 
low birth weight infants.
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INTRODUCTION
Over the past fifteen years, the survival rate of low birth 
weight babies has increased significantly. However, further 
development of these children remains problematic. The 
vast majority of newborns with low birth weight have sig-
nificant restrictions in growth and development during ad-
aptation. About half of these newborns will lag in develop-
ment in the future (1-3). Specific risk factors for impaired 
development and delayed pathology are not well under-
stood (4, 5).
Currently, much attention is paid to the study of lipid me-
tabolism during pregnancy and in newborns in the early 
neonatal period. Cholesterol and triglycerides are important 
components of lipid metabolism, providing necessary lipid 
metabolism and adequate development of the embryo and 
foetus. Cholesterol is crucial for foetal development through-
out pregnancy, as it is an integral part of every cell mem-
brane. The biosynthesis of foetal cholesterol, rather than 
transfer of cholesterol from maternal lipoproteins, is appar-
ently the main mechanism for satisfying foetal needs in later 
stages of pregnancy (6, 7). The physiological and biochemi-
cal mechanisms of the passage of nutrients through the pla-
centa are quite complex. According to studies, triglycerides 
do not pass from mother to foetus [8]. In earlier pregnancy, 
long chain polyunsaturated fatty acids can accumulate in 
the mother’s body and can be transported across the pla-
centa in later stages of pregnancy (9). Thus, a premature 
baby has a high risk of impaired lipid metabolism.
Transition from the intrauterine state to the extrauterine 
state is the most difficult adaptation that occurs in human 
life. Adaptation disorders are often detected after preterm 
delivery (10, 11). Moreover, the state of lipid metabolism is 
very important, as it provides the energy resource necessary 
for the adaptation of newborns and the protection of cell 
membranes from toxic metabolites.
Due to the low ability to break down and absorb lipids, pre-
mature babies can lose 10% to 40% of the fat obtained us-
ing a nutrient substrate (12, 13). Another 15% of fat is lost 
during oxidation and retention of adsorbed triglycerides in 
tissues, which reduces the use of triglycerides as an energy 
source. Therefore, a differentiated approach to replenishing 
energy resources in premature babies of varying degrees of 
maturity is of particular importance (14, 15).
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The aim was prospective assessment of lipid metabolism in 




This study included 173 low birth weight (LBW) newborns 
with birth weight of 500-2,499 grams and gestational age of 
23-37 weeks, including infants with intrauterine growth re-
striction (IUGR).
Study limitations: the study did not include infants with 
birth weight less than 500.0 grams; infants with birth weight 
more than 2499.0 grams; infants with gestational age less 
than 23 weeks; infants with gestational age over 37 weeks; 
infants with surgical pathologies; and infants with infectious 
diseases.
According to their birth weight, all newborns were divided 
into six groups:
1.  42 extremely low birth weight (ELBW) neonates (500 to 
999 grams) without IUGR,
2.  17 ELBW neonates with IUGR,
3.  30 very low birth weight (VLBW) neonates (1,000 to 
1,499 grams) without IUGR,
4.  38 VLBW neonates with IUGR,
5.  30 moderately low birth weight (MLBW) neonates (1,500 
to 2,499 grams) without IUGR, and
6.  16 MLBW neonates with IUGR.
The main characteristics of newborns enrolled in this study 
are shown in Table 1.
Study protocol
LiquickCor-CHOL test systems (1974) were used to quantify 
cholesterol, triglycerides were measured using Liquick- 
Cor-TG test systems (1979), and high- and low-density lipo-
proteins were determined using the CORMAYHDLDIRECT 
test systems (1974). These parameters of lipid metabolism 
were measured on days 10 and 20 of life of the study new-
borns.
From the first day of life, ELBW and VLBW newborns were 
receiving parenteral nutrition in combination with minimal 
trophic nutrition (5-20 mL/kg). Enteral feeding of premature 
VLBW infants was initiated in the late neonatal period (12-
18 days of life). The substrate of enteral nutrition was native 
breast milk or a specialized formula for premature and LBW 
babies. The group of MLBW newborns without significant 
disorders of neonatal adaptation were fed enterally from 
the first day of life (16). No breast milk additives were used.
The study was based on the analysis of the newborn serum 
content of the main indicators of lipid metabolism, such 
as cholesterol, triglycerides, high-density lipoproteins and 
low-density lipoproteins.
Statistical analysis
For continuous variables, descriptive statistics was reported 
as median (Me) and interquartile ranges (lower and upper 
quartiles, LQ, UQ) for non-normal distribution, and as mean 
(M) with standard deviation (SD) for normal distribution. We 
applied Shapiro-Wilk test to check whether the data were 
approximately normally distributed. Binary variables are pre-
sented as frequencies and percentages, n (%).
Mann-Whitney test was used to compare continuous vari-
ables among the groups. We used gamma correlation to 
TABLE 1. Main characteristics of the low birth weight newborns studied
Variable













Gestational age (weeks) 25.8±1.5 29.2±2.2 29.4±1.1 33.6±1.2 32.4±1.5 36.6±0.8
Postconception age (weeks) 29.8±1.47 33.2±2.2 33.4±1.1 36.4±1.5 37.6±1.2 41.6±0.8
Formula feeding, n (%) 42 (100) 17 (100) 15 (50.0) 23 (61.0) 15 (50.0) 9 (44.0)
Extragenital pathology, n (%) 25 (59.5) 10 (58.8) 26 (86.6) 23 (60.5) 15 (50.0) 58 (50.0)
Preeclampsia/eclampsia, n (%) 32 (76.1) 11 (64.7) 18 (60) 28 (73.6) 2 (6.6) 1 (6.3)
Threatening miscarriage, n (%) 38 (90.4) 10 (58.8) 26 (86.6) 22 (57.9) 5 (16.6) 1 (6.3)
Uteroplacental insufficiency, n (%) 40 (95.2) 42 (100) 27 (90.0) 38 (100) 17 (56.6) 15 (93.7)
Placental abruption, n (%) 1 (2.3) 3 (17.6) 0 1 (2.6) 0 1 (6.3)
Smoking, n (%) 5 (11.9) 2 (17.6) 11 (36.3) 9 (23.6) 1 (3.3) 5 (31.2)
Continuous variables are presented as mean values with standard deviation, M±SD; binary variables presented as frequencies and 
percentages, n (%); ELBW = extremely low birth weight; VLBW = very low birth weight; MLBW = moderately low birth weight; IUGR 
= intrauterine growth restriction
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evaluate the strength of pair association between ordinal 
variable and continuous variable. To compare the variables 
within one patient group, we used Wilcoxon test. The point 
biserial correlation was used to measure the strength of pair 
association between the dichotomous variable and contin-
uous variable.
RESULTS
The values of lipid content (cholesterol, triglycerides, high-
density lipoproteins and low-density lipoproteins) obtained 
in the study newborns are shown in Table 2. We noted sig-
nificant differences in their level among the groups of new-
TABLE 2. Distribution of cholesterol, triglyceride, high-density lipoprotein and low-density lipoprotein levels according to 
weight category (mmol/L) and gestational age (day) of infants
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P Chol 0.565 0.605 0.807 0.455 0.673 0.513
P TG 0.434 0.209 0.895 <0.001 0.024 0.308
P HDL 0.048 0.820 0.009 0.495 0.075 0.313
P LDL 0.633 0.118 0.559 0.033 0.006 0.308
Data are presented as median with lower and upper quartiles, Me (LQ, UQ); P
1 = 
p-level of statistical differences (Mann-Whitney test) 
in newborns of similar weight (ELBW or VLBW or MLBW) without IUGR; P
2 
= p-level of statistical differences (Mann-Whitney test) 
between ELBW newborns with and without IUGR; ELBW = extremely low birth weight; VLBW = very low birth weight; MLBW = 
moderately low birth weight; IUGR = intrauterine growth restriction; Chol = cholesterol; TG = triglycerides; HDL = high-density 
 lipoproteins; LDL = low-density lipoproteins.
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borns (Table 2). The lowest cholesterol level was recorded in 
premature ELBW newborns with IUGR throughout the neo-
natal period (median 3.08 mmol/L). ELBW newborns with-
out IUGR also had the lowest cholesterol among all infants 
in late neonatal age (median 3.16 mmol/L). However, in this 
group, there was a tendency to increase cholesterol levels 
in late neonatal age (median 3.12 mmol/L).
The lowest triglycerides levels were found in the groups of 
ELBW and ELBW with IUGR. They were the same in these 
groups in the early neonatal period (median 0.88 mmol/L). 
In the ELBW group with IUGR, the triglyceride level contin-
ued to decline in the late neonatal period (median 0.78 
mmol/L).
The lowest high-density lipoproteins were observed in the 
groups of ELBW and ELBW with IUGR (median 0.82 mmol/L 
and 0.86 mmol/L, respectively), and in VLBW with IUGR in 
early neonatal age (median 0.88 mmol/L). In the latter 
group, high-density lipoprotein level increased in late neo-
natal age (median 0.92 mmol/L). The level of high-density 
lipoproteins did not change in the groups of ELBW and 
ELBW with IUGR in the late neonatal period (median 0.84 
mmol/L and 0.85 mmol/L, respectively).
The same pattern was observed in the evaluation of low-
density lipoproteins. The lowest low-density lipoprotein lev-
els were observed in the groups of ELBW (median 1.88 
mmol/L), ELBW with IUGR (median 1.84 mmol/L) and VLBW 
with IUGR (median 1.84 mmol/L) neonates. In the late neo-
natal period, low-density lipoprotein levels increased only 
in the ELBW group with IUGR (median 1.92 mmol/L).
DISCUSSION
This study showed that in ELBW newborns, the levels of the 
main indicators of the lipid spectrum, such as cholesterol, 
triglycerides, high-density lipoproteins and low-density li-
poproteins, are significantly lower compared to LBW new-
borns. Although the analysis of lipid content in the exam-
ined newborns showed that their content was within the 
reference values, newborns with ELBW with IUGR had sig-
nificantly lower levels of key lipid spectrum indicators, such 
as cholesterol, triglycerides, high-density lipoproteins and 
low-density lipoproteins, compared to newborns with LBW 
(17, 18). The significant differences can be explained by in-
sufficient lipid intake, predominance of catabolic processes, 
deficiency of lipogenesis as a result of morphofunctional 
immaturity in extremely premature infants, and prenatal hy-
poxia caused by intrauterine pathology, as indicated in Ta-
ble 1 (19, 20).
Similar results were obtained by Maslovskaya (17) and Pere-
pelitsa (18). This can be explained by the fact that intensive 
lipid synthesis occurs at the end of a normal pregnancy, 
therefore, premature newborns lack the lipids in the early 
neonatal period due to high demands and low potential for 
their synthesis (4,21). However, these studies were conduct-
ed without taking into account trophic status at birth and in 
the early neonatal period, which is insufficient for complete 
analysis of lipid metabolism in all categories of premature 
infants in the neonatal period. A study by Ramaraj et al. (22), 
on the contrary, denies connection of lipid metabolism in 
foetuses and newborns with different body weights. How-
ever, the results of this study did not show differences in 
lipid levels in particular weight categories of premature ba-
bies and newborns with IUGR throughout the neonatal pe-
riod. Herrera and Ortega-Senovilla (23) discuss the relation-
ship of intrauterine pathology with lipid metabolism of 
newborns, not specifying its nature in different weight cat-
egories of these children. During late gestation, although 
maternal adipose tissue lipolytic activity becomes en-
hanced, lipolytic products cross the placenta with difficulty. 
Under fasting conditions, free fatty acids are used for keto-
genesis by the mother, and ketone bodies are used as fuels 
and lipogenic substrates by the foetus. Maternal glycerol 
is preferentially used for glucose synthesis, saving other 
 gluconeogenic substrates such as amino acids for foetal 
growth. Placental transfer of triglycerides is null, but essen-
tial fatty acids derived from maternal diet, which are trans-
ported as triglycerides in lipoproteins, become available to 
the foetus owing to the presence of both lipoprotein recep-
tors and lipase activities in the placenta. However, prema-
ture infants do not have time to enter this metabolic period, 
as they are born before it begins. Therefore, changes in the 
maternal lipid profile are not significantly associated with 
average concentrations of total cholesterol, low- and high-
density lipoproteins and triglycerides in premature new-
borns (24).
Accordingly, it is necessary to expand the study of methods 
for correcting lipid spectrum in LBW infants for their effi-
cient rehabilitation.
CONCLUSION
The results of the study pointed to the importance of birth 
weight in assessing lipid metabolism in premature infants. 
The lowest level of all components of the lipid spectrum 
(cholesterol, low- and high-density lipoproteins and triglyc-
erides) is due to the extreme immaturity of newborns in 
combination with IUGR. Cholesterol and triglyceride levels 
in newborns with ELBW and IUGR tend to decrease through-
out the neonatal period, while high-density and low-densi-
ty lipoprotein levels increase in the late neonatal period. The 
data obtained may be significant for further research aim-
ing to determine effective methods of enteral and paren-
teral nutrition of premature infants.
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S A Ž E T A K
Lipidni profil u novorođenčadi niske porođajne mase
Yuri V. Chernenkov, Larisa G. Bochkova, Irina I. Kadymova, Anton R. Kiselev
Cilj istraživanja bio je procijeniti metabolizam lipida u nedonoščadi kako bi se utvrdili češći uzorci ovisno o porođajnoj masi. Razine 
kolesterola, triglicerida, lipoproteina niske i visoke gustoće mjerene su u 173 novorođenčadi umjereno niske, vrlo niske i iznimno niske 
porođajne mase, uključujući novorođenčad s intrauterinim zastojem rasta, a svaka se težinska kategorija bilježila tijekom neonatal-
nog razdoblja. Istraživanje je pokazalo da novorođenčad iznimno niske porođajne mase s intrauterinim zastojem rasta i novoro-
đenčad vrlo niske porođajne mase ima značajno niže razine lipidnog profila nego novorođenčad umjereno niske porođajne mase. 
Potrebno je proširiti istraživanje metoda za ispravljanje lipidnog spektra kod novorođenčadi niske porođajne mase radi njihove reha-
bilitacije.
Ključne riječi: KOLESTEROL; INTRAUTERINI ZASTOJ RASTA; LIPOPROTEINI; TRIGLICERIDI
